Literature DB >> 19517112

Paraneoplastic Raynaud's phenomenon in a breast cancer survivor.

David Allen1, David Robinson, Shikha Mittoo.   

Abstract

A 35-year-old woman with a history of breast cancer, treated 3 years ago with surgery, radiation, and chemotherapy presented with a rapid onset of severe Raynaud's phenomenon. On physical examination, she had digital ulcers and splinter hemorrhages; there were no signs of an underlying rheumatic condition. Laboratory evaluation revealed anemia, the presence of antinuclear antibody and slight depression in her serum complement C3 level. The remainder of her serologic evaluation, including extractable nuclear antigens, anti-double-stranded DNA antibody, antiphospholipid antibodies, rheumatoid factor, anti-neutrophil cytoplasmic antibodies, cryoglobulins, and cold agglutins, were negative. Within weeks of her presentation, she developed acute renal failure and bilateral lower extremity edema. A computed tomography scan of her abdomen and pelvis showed bulky lymphadenopathy and hydronephrosis; a pelvic lymph node biopsy revealed metastatic breast cancer. She was initially managed with passive rewarming strategies, topical antibiotics, vasodilator and anti-platelet therapy, but had a negligible response. However, once she was started on chemotherapy for her recurrent malignancy, there was a significant improvement in her Raynaud's symptoms and resolution of her digital ulcers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517112     DOI: 10.1007/s00296-009-0985-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  Malignancies and soluble tumor antigens in rheumatic diseases.

Authors:  Eva Szekanecz; Csilla András; Zsuzsa Sándor; Péter Antal-Szalmás; János Szántó; László Tamási; Emese Kiss; Zoltán Szekanecz
Journal:  Autoimmun Rev       Date:  2006-04-19       Impact factor: 9.754

2.  Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold.

Authors:  S W Hansen; N Olsen
Journal:  J Clin Oncol       Date:  1989-07       Impact factor: 44.544

3.  Scleroderma and breast carcinoma.

Authors:  G Papasavvas; C J Goodwill
Journal:  Br J Rheumatol       Date:  1989-08

4.  Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.

Authors:  B Planchon; M A Pistorius; P Beurrier; P De Faucal
Journal:  Angiology       Date:  1994-08       Impact factor: 3.619

5.  Prevalence of symptoms of Raynaud's phenomenon in general practice.

Authors:  A Silman; S Holligan; P Brennan; P Maddison
Journal:  BMJ       Date:  1990-09-22

Review 6.  Carcinoma of breast and scleroderma: four further cases and a literature review.

Authors:  A M Forbes; J C Woodrow; J L Verbov; R M Graham
Journal:  Br J Rheumatol       Date:  1989-02

Review 7.  Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.

Authors:  Grazyna Adamus
Journal:  Autoimmun Rev       Date:  2003-03       Impact factor: 9.754

Review 8.  Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.

Authors:  Laura K Hummers; Fredrick M Wigley
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

Review 9.  Autonomic paraneoplastic neurological syndromes.

Authors:  Lorenzo Lorusso; Ian K Hart; Daniela Ferrari; Gaelle K Ngonga; Chiara Gasparetto; Giovanni Ricevuti
Journal:  Autoimmun Rev       Date:  2006-11-17       Impact factor: 9.754

Review 10.  Rheumatic disorders as paraneoplastic syndromes.

Authors:  Vito Racanelli; Marcella Prete; Carla Minoia; Elvira Favoino; Federico Perosa
Journal:  Autoimmun Rev       Date:  2008-02-22       Impact factor: 9.754

View more
  4 in total

1.  Paraneoplastic Raynaud's phenomenon manifesting before the diagnosis of lung cancer.

Authors:  Irappa Madabhavi; Swaroop Revannasiddaiah; Madhup Rastogi; Manoj Kumar Gupta
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  A case report of the beneficial effects of botulinum toxin type A on Raynaud phenomenon in a patient with lung cancer.

Authors:  Lu Wang; Qi-Song Lei; Yu-Ying Liu; Guan-Jie Song; Chun-Ling Song
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.

Authors:  Thilo Gambichler; Stefanie Strutzmann; Andrea Tannapfel; Laura Susok
Journal:  BMC Cancer       Date:  2017-05-12       Impact factor: 4.430

4.  Digital ischemia associated with cancer: results from a cohort study.

Authors:  Maëlle Le Besnerais; Sébastien Miranda; Nicole Cailleux; Nicolas Girszyn; Isabelle Marie; Hervé Lévesque; Ygal Benhamou
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.